We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.1B
$69.1B $21.64 0.23%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$48.8B
$48.8B $41.81 1.79%
HLN icon
3
Haleon
HLN
$40B
$40B $9.11 0.98%
ZTS icon
4
Zoetis
ZTS
$33.9B
$33.9B $83.50 1.05%
UTHR icon
5
United Therapeutics
UTHR
$24.5B
$24.5B $576.10 2%
VTRS icon
6
Viatris
VTRS
$23.4B
$23.4B $20.45 1.4%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.6B
$16.6B $163.95 0.82%
ELAN icon
8
Elanco Animal Health
ELAN
$12.9B
$12.9B $25.84 2.16%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.4B
$12.4B $14.84 0.95%
ALKS icon
10
Alkermes
ALKS
$7.6B
$7.6B $45.25 2.75%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.39B
$7.39B $94.09 0.15%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.27B
$7.27B $20.86 1.74%
LNTH icon
13
Lantheus
LNTH
$6.66B
$6.66B $101.79 0.07%
SUPN icon
14
Supernus
SUPN
$6.03B
$6.03B $29.01 0.62%
LQDA icon
15
Liquidia
LQDA
$4.99B
$4.99B $55.41 1.7%
HIMS icon
16
Hims & Hers Health
HIMS
$4.03B
$4.03B $17.21 7.27%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.47B
$3.47B $26.98 2.95%
BHC icon
18
Bausch Health
BHC
$3.1B
$3.1B $8.29 1.54%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.02B
$3.02B $16.53 1.02%
HCM icon
20
HUTCHMED
HCM
$2.5B
$2.5B $14.40 2.24%
PBH icon
21
Prestige Consumer Healthcare
PBH
$2.28B
$2.28B $48.04 0.08%
PRGO icon
22
Perrigo
PRGO
$2.23B
$2.23B $16.09 0.56%
RGC icon
23
Regencell Bioscience
RGC
$2.19B
$2.19B $4.41 6.57%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.91B
$1.91B $7.41 0.54%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.84B
$1.84B $63.73 0.23%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $367B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.1B, Teva Pharmaceutical Industries (TEVA) at $48.8B and Haleon (HLN) at $40B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.